https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Of a total of 163 DBS samples tested positive in primary screening, the 21-hydroxylase-deficient form of CAH was confirmed in 1 sample. The present LC-MS/MS assay was successfully applied as a second-tier test in a cross-border cooperation for newborn screening. The assay allows concurrent confirmation and differential diagnosis of CAH and can be performed on the same DBS samples as in primary screening, enabling early diagnosis and treatment. The present LC-MS/MS assay was successfully applied as a second-tier test in a cr
Aimer
Commentaire
Partagez
